Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants-Reference-Cited by-同舟云学术

Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants

Published:2008-01-15 Issue:3 Volume:15 Page:291-300
ISSN:1021-7770
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Chen Tzu-Chun,Liu Shu-Cheng,Huang Peng-Nien,Chang Hwan-You,Chern Jyh-Haur,Shih Shin-Ru

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry, medical,Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11373-007-9228-5.pdf

Reference37 articles.

1. AbuBakar S, Chan YF, Lam SK (2002) Outbreaks of enterovirus 71 infection. N Engl J Med 342:355–356

2. Alexander JPJ, Baden L, Pallansch MA, Anderson LJ (1994) Enterovirus 71 infections and neurologic disease—United States, 1977–1991. J Infect Dis 169:905–908

3. Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW (1992) Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718–1720

4. Billich A (2000) Pleconaril Sanofi Synthelabo/ViroPharma. Curr Opin Investig Drugs 1:303–307

5. Chang LY, Huang YC, Lin TY (1998) Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352:367–368

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in anti-EV-A71 drug development research;Journal of Advanced Research;2024-02

2. EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors;Viruses;2023-03-18

3. Current therapeutic strategies and novel antiviral compounds for the treatment of nonpolio enteroviruses;Viral Infections and Antiviral Therapies;2023

4. Synthesis of 5-arylidene-3-(pyridin-4-yl)-2-thio-imidazolidinone derivatives with the end of flexible chain modified with aryl groups under microwave;Synthetic Communications;2022-03-04

5. Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition;Scientific Reports;2021-05-06